Abstract
Background Total hip and knee arthroplasties (THAs and TKAs) are some of the most common and successful surgeries. Predicting their duration of surgery (DOS) and length of stay (LOS) has massive implications for costs and resource management. The purpose of this study was to predict the DOS and LOS of THAs using machine learning models (MLMs) based on preoperative factors.
Methods The American College of Surgeons (ACS) National Surgical and Quality Improvement (NSQIP) database was queried for elective unilateral THA procedures. Multiple MLMs were constructed to predict DOS and LOS. Models were evaluated according to mean squared error (MSE), buffer accuracy, and classification accuracy. To ensure useful predictions, the results of the models were compared to a mean regressor and previous MLM predictions for primary TKAs.
Results 196,942 patients were included. The neural network had the best MSE, buffer and training accuracies for both DOS and LOS. For DOS testing, the neural network MSE was 0.916, with the 30-minute buffer and ≤120 min, >120 min accuracies being 75.4% and 88.5%. For LOS testing, the neural network MSE was 0.567, with the 1-day buffer and ≤2 days, >2 accuracies being 70.3% and 80.9%. Slightly reduced performance was found for THA compared to TKA for DOS and LOS (3 to 5%), with similar important features identified.
Conclusion MLMs based on preoperative factors successfully predicted the DOS and LOS of elective unilateral THAs, with similar performance to TKA. Future work should include operational factors to apply these models to real world resource optimization.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The intuitional research board of Sunnybrook Health Sciences Centre gave ethical approval before commencement of this study (Sunnybrook Health Sciences Centre, Project ID #4899).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos